February 2012
Authors : Zhang Xu-song1 , Xiang Bing-ren2
Affliation :
1China Pharmaceutical University, Center for Instrumental Analysis, Ministry of Education, Key Laboratory of Drug Quality Control & Pharmacovigilance, 210009, Nanjing, P.R. China ; ; yxzxs@msn.com
2China Pharmaceutical University, Center for Instrumental Analysis, Ministry of Education, Key Laboratory of Drug Quality Control & Pharmacovigilance, 210009, Nanjing, P.R. China ; cpuxiang@yahoo.com
DOI : 10.1517/13543780802465992
Published in : Expert Opin. Investig. Drugs
Subject:
Keywords: AC-2592 , AZD-6610 , AZD-7009 , AZD-8677 , AZD-9684 , Cardio Vascu-Grow , CETi-1 , CP-778875 , CTI-01 , LXR-623 , LY-518674 , PF-807925 , PF-3052334 , PF-3491165 , Pioglitazone HCl + TAK-536 , YM-758
This perspective is part of an annual series of...
Please Login to read the full article.
